INNOCAN PHARMA CORPORATION financial statements, including revenue, expenses, profit, and loss
The total revenue of IP4 for the last quarter is 7.81 M EUR, and it's 3.23% lower compared to the previous quarter. The net income of Q3 24 is -262.56 k EUR.